Menu
Search
|

Menu

Close
X

Psychemedics Corp PMD.OQ (NASDAQ Stock Exchange Capital Market)

18.60 USD
+0.00 (+0.00%)
As of Oct 16
chart
Previous Close 18.60
Open 18.63
Volume 799
3m Avg Volume 3,045
Today’s High 18.65
Today’s Low 18.60
52 Week High 22.88
52 Week Low 16.28
Shares Outstanding (mil) 5.49
Market Capitalization (mil) 100.61
Forward P/E 13.54
Dividend (Yield %) 0.15 ( 3.28 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, USD)
FY18
22
FY17
40
FY16
39
FY15
27
EPS (USD)
FY18
0.437
FY17
1.321
FY16
1.214
FY15
0.279
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
13.54
33.73
Price to Sales (TTM)
vs sector
2.37
5.82
Price to Book (MRQ)
vs sector
6.12
4.90
Price to Cash Flow (TTM)
vs sector
9.98
22.98
Total Debt to Equity (MRQ)
vs sector
9.77
16.96
LT Debt to Equity (MRQ)
vs sector
6.47
12.63
Return on Investment (TTM)
vs sector
38.25
14.31
Return on Equity (TTM)
vs sector
52.87
16.04

EXECUTIVE LEADERSHIP

Raymond Kubacki
Chairman of the Board, President, Chief Executive Officer, Since 2003
Salary: $429,510.00
Bonus: $107,377.00
Neil Lerner
Vice President - Finance, Since 2014
Salary: --
Bonus: --
Michael Schaffer
Vice President - Laboratory Operations, Since 1999
Salary: $248,230.00
Bonus: $62,057.00
James Abely
Vice President, General Counsel, Since 2018
Salary: --
Bonus: --
A. Clinton Allen
Independent Director, Since 2015
Salary: $186,058.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Healthcare Facilities & Services
Address:

125 Nagog Park Ste 200
ACTON   MA   01720-3451

Phone: +1800.6288073

Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.

SPONSORED STORIES